Skip to main content
Watch Insiders
KROS filings

Corporate insider profile

Jean Jacques Bienaime Filing Activity

Latest reported as Director of Keros Therapeutics, Inc. (KROS).

Purchase filings
7
Reported companies
3
Net open-market value
$750,733
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

KROSLatest reported

Keros Therapeutics, Inc.

Director

IMNMPrior filing

Immunome Inc.

Director

ASNDPrior filing

Ascendis Pharma A/S

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Keros Therapeutics, Inc. (KROS)DirectorOpen Market Purchase1,000$10.19$10,190
Jun 5, 2026Immunome Inc. (IMNM)DirectorOpen Market Purchase21,000$19.43$408,080
May 29, 2026Ascendis Pharma A/S (ASND)DirectorOpen Market Purchase500$223.12$111,562
Subscribe to see more data